3,4-二氨基吡啶 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "3,4-二氨基吡啶" in Chinese language version.

refsWebsite

Global rank Chinese rank

5web.archive.org

1^st place

1^st place

3,984^th place

1,603^rd place

low place

low place

68^th place

209^th place

europa.eu

ema.europa.eu

Firdapse Summary of Product Characteristics (PDF). EMA. February 11, 2010 [2022-11-04]. （原始内容存档 (PDF)于2018-06-20）. See EMA Index page, product tab （页面存档备份，存于互联网档案馆）

hres.ca

hpr-rps.hres.ca

Summary Basis of Decision (SBD) for Firdapse. Health Canada. 23 October 2014 [29 May 2022]. （原始内容存档于2022-11-04）.
Summary Basis of Decision (SBD) for Ruzurgi. Health Canada. 23 October 2014 [29 May 2022]. （原始内容存档于2022-11-02）.

tga.gov.au

Ruzurgi. Therapeutic Goods Administration (TGA). 24 September 2021 [30 September 2021]. （原始内容存档于2021-09-30）.
Updates to the Prescribing Medicines in Pregnancy database. Therapeutic Goods Administration (TGA). 12 May 2022 [13 May 2022]. （原始内容存档于2022-04-03）.

web.archive.org

Ruzurgi. Therapeutic Goods Administration (TGA). 24 September 2021 [30 September 2021]. （原始内容存档于2021-09-30）.
Updates to the Prescribing Medicines in Pregnancy database. Therapeutic Goods Administration (TGA). 12 May 2022 [13 May 2022]. （原始内容存档于2022-04-03）.
Summary Basis of Decision (SBD) for Firdapse. Health Canada. 23 October 2014 [29 May 2022]. （原始内容存档于2022-11-04）.
Summary Basis of Decision (SBD) for Ruzurgi. Health Canada. 23 October 2014 [29 May 2022]. （原始内容存档于2022-11-02）.
Firdapse Summary of Product Characteristics (PDF). EMA. February 11, 2010 [2022-11-04]. （原始内容存档 (PDF)于2018-06-20）. See EMA Index page, product tab （页面存档备份，存于互联网档案馆）